Kepos Capital LP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 273 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kepos Capital LP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2019$935,000
-61.6%
19,363
-59.8%
0.10%
-48.1%
Q1 2019$2,436,000
-14.8%
48,2190.0%0.18%
-17.2%
Q4 2018$2,858,000
-10.0%
48,2190.0%0.22%
+35.6%
Q3 2018$3,174,000
+30.3%
48,2190.0%0.16%
+31.5%
Q2 2018$2,435,000
+356.0%
48,219
+375.8%
0.12%
+300.0%
Q1 2018$534,00010,1340.03%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Zebra Capital Management LLC 20,591$895,0001.43%
Global Alpha Capital Management Ltd. 330,270$14,357,0001.39%
AIMZ Investment Advisors, LLC 73,875$3,211,0001.25%
Hillcrest Asset Management LLC 184,010$7,999,0001.22%
Bridge City Capital, LLC 56,869$2,472,0001.02%
SNYDER CAPITAL MANAGEMENT L P 683,700$29,720,0000.72%
EARNEST PARTNERS LLC 2,188,606$95,139,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 343,347$14,925,0000.53%
PALISADE CAPITAL MANAGEMENT, LP 584,957$25,428,0000.52%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 45,693$1,986,0000.45%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders